Clinical trial
A Phase I/Pilot II Trial Combining Decitabine and Vaccine Therapy for Patients With Relapsed or Refractory Pediatric High Grade Gliomas, Medulloblastomas, and Central Nervous System Primitive Neuroectodermal Tumors (CNS PNETs)
NCT02332889 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/Pilot II Trial Combining Decitabine and Vaccine Therapy for Patients With Relapsed or Refractory Pediatric High Grade Gliomas, Medulloblastomas, and Central Nervous System Primitive Neuroectodermal Tumors (CNS PNETs)
- Lead sponsor
- University of Louisville
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- April 30, 2015
- Completion date
- July 31, 2016
- Enrollment
- 1 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.